Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1Breast 1

Conditions

Leukemia, Myeloid, Acute 14Leukemia 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Myelodysplastic Syndromes 10Leukemia, Lymphocytic, Chronic, B-Cell 10Lymphoma, Non-Hodgkin 9Leukemia, Myeloid, Accelerated Phase 9Multiple Myeloma 8Leukemia, Myelomonocytic, Chronic 8Leukemia, Myeloid, Chronic-Phase 8Myeloproliferative Disorders 7Lymphoma, Mantle-Cell 7Lymphoma, Follicular 7Hodgkin Disease 7Congenital Abnormalities 7Lymphoma, Large B-Cell, Diffuse 6Lymphoma, B-Cell, Marginal Zone 6Carcinoma, Renal Cell 6Blast Crisis 6Lymphoma, Large-Cell, Immunoblastic 5Lymphoma 5Burkitt Lymphoma 5Thrombocythemia, Essential 4Polycythemia Vera 4Pdgfra-Associated Chronic Eosinophilic Leukemia 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, T-Cell, Cutaneous 4Leukemia, Neutrophilic, Chronic 4Waldenstrom Macroglobulinemia 3Sezary Syndrome 3

Interventions

pembrolizumab 6aldesleukin 6Cyclophosphamide 6fludarabine phosphate 5fludarabine 5Nivolumab 4durvalumab 3Sorafenib 3Radiotherapy 3Filgrastim 3Everolimus 3Axitinib 3Temozolomide 2Peripheral Blood Stem Cell Transplantation 2Isotretinoin 2Ipilimumab 2Interleukin-2 2Interferon-alpha 2Fluorouracil 2Dexamethasone 2Cyclosporine 2Bevacizumab 2vorolanib 1tremelimumab 1tocilizumab 1talazoparib 1spartalizumab 1sargramostim 1poly ICLC 1palbociclib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1/2 × Kidney Neoplasms × Cyclosporine × Clear all
NCT00365287 2017-11-29

Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer

Masonic Cancer Center, University of Minnesota

Phase 1/2 Completed
148 enrolled
BreastClassical hematologyGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Congenital Abnormalities, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Breast Neoplasms, Burkitt Lymphoma, Carcinoma, Renal Cell, Hodgkin Disease, Kidney Neoplasms, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating

NCT00006968 2013-01-08

Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer

Jonsson Comprehensive Cancer Center

Phase 1/2 Completed
4 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡